| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracellular Signaling Peptides and Proteins | 35 | 2015 | 2916 | 3.220 |
Why?
|
| Cysteine Endopeptidases | 14 | 2015 | 563 | 2.050 |
Why?
|
| NF-kappa B | 34 | 2015 | 2501 | 1.760 |
Why?
|
| Endothelium, Vascular | 36 | 2013 | 4455 | 1.640 |
Why?
|
| Nuclear Proteins | 29 | 2014 | 5853 | 1.580 |
Why?
|
| Proteins | 24 | 2006 | 6101 | 1.430 |
Why?
|
| DNA-Binding Proteins | 31 | 2014 | 9647 | 1.370 |
Why?
|
| Muscle, Smooth, Vascular | 13 | 2015 | 1504 | 1.330 |
Why?
|
| Arteriosclerosis | 5 | 2016 | 1092 | 1.220 |
Why?
|
| Liver Regeneration | 5 | 2015 | 210 | 1.200 |
Why?
|
| Tumor Necrosis Factor-alpha | 39 | 2016 | 4419 | 1.040 |
Why?
|
| Apoptosis | 27 | 2015 | 9728 | 0.990 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 10 | 2013 | 1434 | 0.890 |
Why?
|
| Aorta | 10 | 2016 | 2061 | 0.850 |
Why?
|
| Graft Rejection | 22 | 2015 | 4399 | 0.630 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2012 | 416 | 0.580 |
Why?
|
| I-kappa B Proteins | 6 | 2005 | 225 | 0.570 |
Why?
|
| Transplantation, Heterologous | 16 | 1999 | 2382 | 0.560 |
Why?
|
| Transfection | 19 | 2010 | 5892 | 0.550 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 9 | 1991 | 906 | 0.540 |
Why?
|
| Interferon-gamma | 15 | 2021 | 3203 | 0.540 |
Why?
|
| Liver | 6 | 2015 | 7472 | 0.530 |
Why?
|
| Islets of Langerhans | 5 | 2003 | 1350 | 0.510 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 329 | 0.500 |
Why?
|
| Inflammation | 12 | 2015 | 10634 | 0.480 |
Why?
|
| Hepatectomy | 4 | 2015 | 550 | 0.460 |
Why?
|
| Interferon-beta | 2 | 2014 | 323 | 0.460 |
Why?
|
| Transplantation, Homologous | 12 | 2016 | 4776 | 0.450 |
Why?
|
| Zinc Fingers | 5 | 2005 | 585 | 0.440 |
Why?
|
| Interleukin-6 | 6 | 2016 | 3201 | 0.430 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 176 | 0.420 |
Why?
|
| Tunica Intima | 3 | 2016 | 464 | 0.410 |
Why?
|
| Mice, Inbred BALB C | 13 | 2016 | 6386 | 0.410 |
Why?
|
| Liver Failure | 2 | 2005 | 241 | 0.400 |
Why?
|
| Dermis | 1 | 2013 | 207 | 0.400 |
Why?
|
| Adenoviridae | 12 | 2015 | 1099 | 0.400 |
Why?
|
| Animals | 91 | 2024 | 168788 | 0.390 |
Why?
|
| Cytokines | 18 | 2014 | 7326 | 0.390 |
Why?
|
| Hyperplasia | 6 | 2024 | 1184 | 0.380 |
Why?
|
| Cells, Cultured | 26 | 2015 | 19227 | 0.380 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 270 | 0.380 |
Why?
|
| Graft Survival | 10 | 2006 | 3740 | 0.360 |
Why?
|
| Lymphocyte Activation | 12 | 1996 | 5523 | 0.350 |
Why?
|
| Cell Proliferation | 10 | 2024 | 10480 | 0.350 |
Why?
|
| Hepatocytes | 7 | 2015 | 1210 | 0.340 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 874 | 0.330 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 1991 | 2540 | 0.330 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2014 | 1789 | 0.320 |
Why?
|
| Atherosclerosis | 3 | 2014 | 3444 | 0.320 |
Why?
|
| PPAR alpha | 1 | 2009 | 196 | 0.320 |
Why?
|
| Endothelial Cells | 6 | 2020 | 3478 | 0.300 |
Why?
|
| Antibodies, Monoclonal | 24 | 2004 | 9275 | 0.300 |
Why?
|
| Gene Expression Regulation | 12 | 2014 | 12075 | 0.290 |
Why?
|
| Cattle | 9 | 2013 | 3922 | 0.290 |
Why?
|
| Cytoprotection | 6 | 2014 | 210 | 0.290 |
Why?
|
| Receptors, Tumor Necrosis Factor | 4 | 2002 | 595 | 0.290 |
Why?
|
| Ubiquitin | 2 | 2015 | 852 | 0.280 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2015 | 365 | 0.280 |
Why?
|
| Lipid Metabolism | 2 | 2015 | 1888 | 0.280 |
Why?
|
| Mice | 37 | 2021 | 81178 | 0.280 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2010 | 1121 | 0.280 |
Why?
|
| U937 Cells | 3 | 2014 | 268 | 0.270 |
Why?
|
| Complement System Proteins | 6 | 2020 | 795 | 0.260 |
Why?
|
| Minor Histocompatibility Antigens | 5 | 2013 | 298 | 0.260 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 1438 | 0.250 |
Why?
|
| E-Selectin | 6 | 1998 | 579 | 0.240 |
Why?
|
| Immunity, Innate | 3 | 2015 | 2958 | 0.240 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2002 | 171 | 0.240 |
Why?
|
| RNA, Small Interfering | 7 | 2024 | 3505 | 0.240 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2016 | 687 | 0.230 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 1860 | 0.230 |
Why?
|
| Swine | 15 | 2006 | 5940 | 0.220 |
Why?
|
| T-Lymphocytes | 13 | 1997 | 10182 | 0.220 |
Why?
|
| Reperfusion Injury | 1 | 2009 | 1026 | 0.220 |
Why?
|
| Carotid Arteries | 3 | 2015 | 952 | 0.220 |
Why?
|
| Interleukin-1 | 7 | 1999 | 1263 | 0.210 |
Why?
|
| Up-Regulation | 7 | 2015 | 4217 | 0.210 |
Why?
|
| Autoimmune Diseases | 2 | 2014 | 2136 | 0.210 |
Why?
|
| Protein Biosynthesis | 4 | 2003 | 2126 | 0.210 |
Why?
|
| Gelatin | 1 | 2024 | 225 | 0.210 |
Why?
|
| Homeodomain Proteins | 3 | 2001 | 2422 | 0.210 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2001 | 1888 | 0.200 |
Why?
|
| CD40 Ligand | 1 | 2003 | 526 | 0.200 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2004 | 744 | 0.200 |
Why?
|
| Signal Transduction | 11 | 2021 | 23404 | 0.190 |
Why?
|
| Kidney Transplantation | 10 | 2005 | 4251 | 0.190 |
Why?
|
| Renal Artery | 1 | 2003 | 398 | 0.190 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2013 | 1155 | 0.190 |
Why?
|
| Neural Stem Cells | 2 | 2020 | 850 | 0.190 |
Why?
|
| Monocytes | 5 | 2010 | 2594 | 0.190 |
Why?
|
| Models, Animal | 4 | 2013 | 2171 | 0.190 |
Why?
|
| Liver Transplantation | 2 | 2009 | 2118 | 0.180 |
Why?
|
| Repressor Proteins | 3 | 2001 | 3023 | 0.180 |
Why?
|
| Vascular System Injuries | 1 | 2024 | 250 | 0.180 |
Why?
|
| Proto-Oncogenes | 1 | 2001 | 321 | 0.180 |
Why?
|
| Energy Metabolism | 2 | 2011 | 2895 | 0.180 |
Why?
|
| Gene Expression | 9 | 2009 | 7799 | 0.180 |
Why?
|
| Lipopolysaccharides | 5 | 2014 | 2216 | 0.180 |
Why?
|
| bcl-X Protein | 4 | 2003 | 411 | 0.180 |
Why?
|
| Protein Engineering | 1 | 2003 | 540 | 0.170 |
Why?
|
| Nitric Oxide | 4 | 2010 | 2131 | 0.170 |
Why?
|
| Microbubbles | 1 | 2020 | 128 | 0.170 |
Why?
|
| Luciferases | 3 | 2013 | 733 | 0.170 |
Why?
|
| Rats | 19 | 2024 | 24273 | 0.160 |
Why?
|
| Interferons | 2 | 2020 | 706 | 0.160 |
Why?
|
| Macrophages | 2 | 2010 | 5657 | 0.160 |
Why?
|
| Epithelial Cells | 2 | 2012 | 3690 | 0.160 |
Why?
|
| Caspase 8 | 3 | 2009 | 195 | 0.160 |
Why?
|
| Killer Cells, Natural | 3 | 2004 | 2133 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2014 | 15525 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 21824 | 0.150 |
Why?
|
| Vasculitis | 2 | 2001 | 521 | 0.150 |
Why?
|
| Galactosamine | 2 | 2009 | 30 | 0.140 |
Why?
|
| Recombinant Proteins | 7 | 2003 | 6612 | 0.140 |
Why?
|
| Antigens, CD | 4 | 1997 | 4026 | 0.140 |
Why?
|
| Thiocarbamates | 1 | 1995 | 31 | 0.140 |
Why?
|
| Genetic Vectors | 8 | 2010 | 3420 | 0.130 |
Why?
|
| Phosphorylation | 5 | 2014 | 8437 | 0.130 |
Why?
|
| Mice, Knockout | 5 | 2015 | 14556 | 0.130 |
Why?
|
| Cyclin A | 1 | 2015 | 60 | 0.130 |
Why?
|
| Cell Movement | 4 | 2014 | 5216 | 0.130 |
Why?
|
| Humans | 81 | 2021 | 744220 | 0.130 |
Why?
|
| Adenoviruses, Human | 1 | 1997 | 257 | 0.130 |
Why?
|
| Endothelium | 1 | 1997 | 778 | 0.130 |
Why?
|
| Polyvinyl Alcohol | 1 | 2015 | 74 | 0.120 |
Why?
|
| Cyclin E | 1 | 2015 | 172 | 0.120 |
Why?
|
| Mice, Inbred CBA | 2 | 1993 | 448 | 0.120 |
Why?
|
| Hydrogen Peroxide | 3 | 2009 | 731 | 0.120 |
Why?
|
| Electrochemical Techniques | 1 | 2015 | 98 | 0.120 |
Why?
|
| Necrosis | 3 | 2009 | 1643 | 0.120 |
Why?
|
| RNA, Messenger | 9 | 2015 | 13036 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15294 | 0.120 |
Why?
|
| Cytotoxins | 1 | 2015 | 153 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 2915 | 0.120 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 1016 | 0.120 |
Why?
|
| Enzyme Activation | 4 | 2010 | 3701 | 0.120 |
Why?
|
| Interleukin-3 | 2 | 1991 | 441 | 0.120 |
Why?
|
| Mice, Inbred DBA | 2 | 1991 | 642 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2020 | 8302 | 0.110 |
Why?
|
| Pyrrolidines | 1 | 1995 | 342 | 0.110 |
Why?
|
| STAT1 Transcription Factor | 1 | 2014 | 320 | 0.110 |
Why?
|
| Fas-Associated Death Domain Protein | 2 | 2004 | 27 | 0.110 |
Why?
|
| Cyclin D1 | 1 | 2015 | 462 | 0.110 |
Why?
|
| Antilymphocyte Serum | 2 | 1998 | 492 | 0.110 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4742 | 0.110 |
Why?
|
| Gene Silencing | 2 | 2010 | 1538 | 0.110 |
Why?
|
| Replication Protein C | 3 | 2001 | 19 | 0.100 |
Why?
|
| Heme Oxygenase-1 | 3 | 2014 | 381 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17449 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 3769 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2015 | 5180 | 0.100 |
Why?
|
| Cycloheximide | 2 | 2004 | 347 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4752 | 0.100 |
Why?
|
| Muromonab-CD3 | 7 | 1993 | 96 | 0.100 |
Why?
|
| Heart Transplantation | 5 | 1999 | 3123 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 498 | 0.100 |
Why?
|
| Cerebral Ventricles | 1 | 2014 | 544 | 0.100 |
Why?
|
| Caspases | 3 | 2004 | 928 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 3 | 1995 | 1602 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2011 | 7723 | 0.100 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 1107 | 0.090 |
Why?
|
| Microcirculation | 2 | 2013 | 1286 | 0.090 |
Why?
|
| Encephalitis | 1 | 2014 | 423 | 0.090 |
Why?
|
| Cell Division | 2 | 2009 | 4567 | 0.090 |
Why?
|
| Down-Regulation | 3 | 2021 | 3001 | 0.090 |
Why?
|
| Transcriptional Activation | 3 | 2003 | 1782 | 0.090 |
Why?
|
| Veins | 2 | 2012 | 769 | 0.090 |
Why?
|
| Viruses | 1 | 2014 | 374 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2011 | 12207 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 689 | 0.090 |
Why?
|
| Neointima | 1 | 2010 | 135 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3617 | 0.090 |
Why?
|
| Chemokine CCL2 | 2 | 2005 | 617 | 0.080 |
Why?
|
| Oxidants | 1 | 2009 | 164 | 0.080 |
Why?
|
| Saphenous Vein | 2 | 2010 | 532 | 0.080 |
Why?
|
| Organ Transplantation | 1 | 1999 | 1139 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 123 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2505 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4553 | 0.080 |
Why?
|
| Liver Failure, Acute | 1 | 2009 | 165 | 0.080 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 2078 | 0.080 |
Why?
|
| Glycosylation | 1 | 2010 | 1126 | 0.080 |
Why?
|
| Antioxidants | 1 | 1995 | 1663 | 0.070 |
Why?
|
| Blood Vessels | 2 | 2006 | 1126 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 1351 | 0.070 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2006 | 255 | 0.070 |
Why?
|
| Tissue Donors | 1 | 1996 | 2242 | 0.070 |
Why?
|
| Binding Sites | 2 | 2011 | 6116 | 0.070 |
Why?
|
| Vasodilation | 1 | 2010 | 944 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 2503 | 0.070 |
Why?
|
| Interleukin-8 | 3 | 1998 | 690 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3846 | 0.070 |
Why?
|
| Gene Transfer Techniques | 2 | 2003 | 1224 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 3 | 1991 | 1854 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 1997 | 264 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2014 | 1254 | 0.060 |
Why?
|
| Caspase 3 | 2 | 2004 | 759 | 0.060 |
Why?
|
| Cricetinae | 4 | 1999 | 2472 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2012 | 2938 | 0.060 |
Why?
|
| Mice, Nude | 1 | 1991 | 3689 | 0.060 |
Why?
|
| Caspase 6 | 1 | 2004 | 15 | 0.060 |
Why?
|
| Membrane Proteins | 4 | 2014 | 7879 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2005 | 3129 | 0.060 |
Why?
|
| Plasmids | 3 | 2001 | 2307 | 0.060 |
Why?
|
| Nephritis | 1 | 2005 | 158 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2010 | 1423 | 0.060 |
Why?
|
| Valine | 1 | 2006 | 413 | 0.060 |
Why?
|
| Rats, Inbred Strains | 4 | 2003 | 2191 | 0.060 |
Why?
|
| Transcription Factor RelA | 3 | 2002 | 275 | 0.060 |
Why?
|
| Acute Disease | 2 | 2014 | 7148 | 0.060 |
Why?
|
| Body Temperature | 3 | 1991 | 777 | 0.060 |
Why?
|
| Coronary Vessels | 3 | 2010 | 3107 | 0.060 |
Why?
|
| Fatty Liver | 1 | 2009 | 729 | 0.060 |
Why?
|
| Mice, Inbred A | 1 | 2003 | 248 | 0.060 |
Why?
|
| Lymphocyte Depletion | 2 | 2004 | 608 | 0.060 |
Why?
|
| Thrombospondins | 1 | 2024 | 197 | 0.060 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 453 | 0.050 |
Why?
|
| Genes, bcl-2 | 1 | 2003 | 122 | 0.050 |
Why?
|
| Brain Chemistry | 6 | 1984 | 982 | 0.050 |
Why?
|
| Cell Line | 5 | 2020 | 15999 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 1997 | 1547 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 1708 | 0.050 |
Why?
|
| Motor Activity | 5 | 1991 | 2714 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2006 | 11368 | 0.050 |
Why?
|
| Cadherins | 1 | 2007 | 907 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2010 | 3506 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 2513 | 0.050 |
Why?
|
| Protective Agents | 1 | 2003 | 156 | 0.050 |
Why?
|
| Genetic Engineering | 3 | 1997 | 952 | 0.050 |
Why?
|
| Coculture Techniques | 3 | 2020 | 1341 | 0.050 |
Why?
|
| DNA Primers | 1 | 2006 | 2892 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8661 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2011 | 5867 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2002 | 534 | 0.050 |
Why?
|
| Thromboplastin | 1 | 2003 | 291 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2007 | 2967 | 0.050 |
Why?
|
| Carbon Monoxide | 1 | 2004 | 531 | 0.050 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2020 | 54 | 0.050 |
Why?
|
| Tetrazoles | 1 | 2006 | 836 | 0.050 |
Why?
|
| Genes | 2 | 1999 | 1893 | 0.050 |
Why?
|
| Fas Ligand Protein | 1 | 2001 | 217 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2013 | 1812 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 2 | 2002 | 916 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2014 | 9147 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2004 | 3336 | 0.040 |
Why?
|
| Ubiquitination | 2 | 2015 | 1011 | 0.040 |
Why?
|
| Interleukin-2 | 6 | 1992 | 1904 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2002 | 424 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 2636 | 0.040 |
Why?
|
| Lactates | 2 | 1981 | 432 | 0.040 |
Why?
|
| Genes, Dominant | 3 | 1998 | 880 | 0.040 |
Why?
|
| Agranulocytosis | 1 | 1979 | 100 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2001 | 6172 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2001 | 381 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5169 | 0.040 |
Why?
|
| Syndrome | 4 | 1993 | 3250 | 0.040 |
Why?
|
| Lymphotoxin-alpha | 1 | 1998 | 96 | 0.040 |
Why?
|
| Sucrose | 2 | 1991 | 164 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 1999 | 144 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2004 | 1355 | 0.040 |
Why?
|
| Kidney | 2 | 2005 | 7183 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 528 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9735 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2003 | 1841 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18027 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2006 | 1161 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1999 | 898 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2020 | 5021 | 0.040 |
Why?
|
| Immunogenetics | 1 | 1997 | 67 | 0.040 |
Why?
|
| Complement Inactivator Proteins | 1 | 1997 | 79 | 0.040 |
Why?
|
| Cell Communication | 2 | 2002 | 1621 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2005 | 3461 | 0.040 |
Why?
|
| Granulocytes | 1 | 1979 | 547 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2013 | 3747 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 627 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13096 | 0.040 |
Why?
|
| Pyridazines | 4 | 1984 | 202 | 0.040 |
Why?
|
| Wnt Proteins | 1 | 2020 | 721 | 0.040 |
Why?
|
| Trioses | 1 | 1976 | 3 | 0.040 |
Why?
|
| Diphosphoglyceric Acids | 1 | 1976 | 32 | 0.040 |
Why?
|
| Dihydroxyacetone | 1 | 1976 | 8 | 0.030 |
Why?
|
| Regeneration | 1 | 2005 | 1485 | 0.030 |
Why?
|
| Antibodies | 3 | 2007 | 2461 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2008 | 323 | 0.030 |
Why?
|
| Ischemia | 1 | 2005 | 1914 | 0.030 |
Why?
|
| Male | 18 | 2020 | 350027 | 0.030 |
Why?
|
| Brain | 5 | 2020 | 26413 | 0.030 |
Why?
|
| Genes, jun | 1 | 1995 | 71 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1997 | 281 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1997 | 821 | 0.030 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2002 | 572 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1995 | 79 | 0.030 |
Why?
|
| Calcium | 1 | 2009 | 5757 | 0.030 |
Why?
|
| Biological Transport | 1 | 2020 | 2120 | 0.030 |
Why?
|
| Genes, Bacterial | 2 | 1991 | 1079 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2925 | 0.030 |
Why?
|
| Th2 Cells | 2 | 1997 | 1061 | 0.030 |
Why?
|
| Dogs | 2 | 2012 | 3913 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 1701 | 0.030 |
Why?
|
| Diffuse Axonal Injury | 1 | 2014 | 49 | 0.030 |
Why?
|
| Thioredoxins | 1 | 1995 | 213 | 0.030 |
Why?
|
| Receptors, Vasopressin | 1 | 2014 | 112 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6313 | 0.030 |
Why?
|
| Histocompatibility | 1 | 2015 | 330 | 0.030 |
Why?
|
| Diarrhea | 2 | 1991 | 1347 | 0.030 |
Why?
|
| Monitoring, Immunologic | 2 | 1990 | 100 | 0.030 |
Why?
|
| Genome, Viral | 1 | 1997 | 667 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2002 | 1372 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 528 | 0.030 |
Why?
|
| Laparotomy | 2 | 1973 | 473 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19907 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 1996 | 800 | 0.030 |
Why?
|
| Leukemia | 1 | 1981 | 1508 | 0.030 |
Why?
|
| Skin | 1 | 2006 | 4363 | 0.030 |
Why?
|
| Prosencephalon | 1 | 2014 | 303 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2005 | 10250 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 1979 | 1296 | 0.030 |
Why?
|
| Shock, Hemorrhagic | 2 | 1984 | 220 | 0.030 |
Why?
|
| Histamine Release | 1 | 1991 | 142 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 794 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1799 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 1993 | 964 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 377 | 0.020 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2010 | 5 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1993 | 573 | 0.020 |
Why?
|
| Species Specificity | 2 | 1995 | 2480 | 0.020 |
Why?
|
| Biogenic Amines | 4 | 1984 | 50 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 9438 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4385 | 0.020 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 1991 | 23 | 0.020 |
Why?
|
| Mitochondria | 1 | 2004 | 3520 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1993 | 645 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1991 | 902 | 0.020 |
Why?
|
| Air Pressure | 1 | 2010 | 75 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 1993 | 547 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1994 | 3871 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1991 | 1827 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1993 | 625 | 0.020 |
Why?
|
| Biopsy | 2 | 1993 | 6757 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1993 | 707 | 0.020 |
Why?
|
| RNA Interference | 2 | 2010 | 2890 | 0.020 |
Why?
|
| Corticosterone | 1 | 1990 | 310 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 290 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 216 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2014 | 895 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 843 | 0.020 |
Why?
|
| Insulin | 2 | 2003 | 6583 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2009 | 82 | 0.020 |
Why?
|
| Receptors, Purinergic | 1 | 2009 | 66 | 0.020 |
Why?
|
| Interferon Type I | 2 | 1990 | 542 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2726 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2218 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 242 | 0.020 |
Why?
|
| Child, Institutionalized | 1 | 1969 | 108 | 0.020 |
Why?
|
| Hypothermia | 1 | 1990 | 189 | 0.020 |
Why?
|
| Lymphatic System | 1 | 1990 | 253 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2009 | 180 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1991 | 404 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15161 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 10949 | 0.020 |
Why?
|
| Spleen | 1 | 1994 | 2361 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 297 | 0.020 |
Why?
|
| Time Factors | 5 | 2008 | 40063 | 0.020 |
Why?
|
| Neoplasms | 2 | 2014 | 21672 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1997 | 1352 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 913 | 0.020 |
Why?
|
| Hodgkin Disease | 2 | 1973 | 1415 | 0.020 |
Why?
|
| Salmonella | 1 | 1987 | 129 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1991 | 4220 | 0.020 |
Why?
|
| Polysomnography | 1 | 2013 | 1775 | 0.020 |
Why?
|
| Astrocytes | 1 | 2014 | 1270 | 0.020 |
Why?
|
| Models, Biological | 3 | 1997 | 9582 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1976 | 2454 | 0.020 |
Why?
|
| Nucleotides | 1 | 2009 | 464 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 977 | 0.020 |
Why?
|
| Interleukins | 1 | 1990 | 791 | 0.020 |
Why?
|
| Cell Survival | 2 | 2009 | 5881 | 0.020 |
Why?
|
| Placebos | 1 | 1969 | 1677 | 0.020 |
Why?
|
| Antibodies, Heterophile | 2 | 1995 | 126 | 0.020 |
Why?
|
| Propidium | 1 | 2004 | 41 | 0.020 |
Why?
|
| Annexin A5 | 1 | 2004 | 103 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2005 | 251 | 0.020 |
Why?
|
| Adult | 9 | 2013 | 214035 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2004 | 188 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2005 | 520 | 0.010 |
Why?
|
| Fever | 1 | 1991 | 1614 | 0.010 |
Why?
|
| Reperfusion | 1 | 2005 | 284 | 0.010 |
Why?
|
| Lysosomes | 1 | 2009 | 893 | 0.010 |
Why?
|
| Primates | 2 | 1997 | 544 | 0.010 |
Why?
|
| Forecasting | 1 | 1993 | 2949 | 0.010 |
Why?
|
| Adolescent | 5 | 2002 | 85759 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 443 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 215 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 987 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1991 | 1169 | 0.010 |
Why?
|
| Middle Aged | 7 | 2013 | 213367 | 0.010 |
Why?
|
| Catecholamines | 1 | 1984 | 387 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 743 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2005 | 625 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1987 | 1401 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2007 | 845 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 1525 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2002 | 40992 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 1982 | 117 | 0.010 |
Why?
|
| Piracetam | 1 | 1982 | 87 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 2006 | 4929 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 11732 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 404 | 0.010 |
Why?
|
| Electrophoresis | 1 | 2002 | 240 | 0.010 |
Why?
|
| Th1 Cells | 2 | 1997 | 1057 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1987 | 4321 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2004 | 844 | 0.010 |
Why?
|
| Central Nervous System Stimulants | 1 | 1969 | 1148 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 820 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1640 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1981 | 399 | 0.010 |
Why?
|
| Thrombosis | 1 | 1994 | 2968 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 2032 | 0.010 |
Why?
|
| Cadmium Poisoning | 1 | 1980 | 11 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2505 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 1992 | 2957 | 0.010 |
Why?
|
| Female | 8 | 2020 | 380197 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2004 | 1877 | 0.010 |
Why?
|
| Marine Toxins | 1 | 1979 | 24 | 0.010 |
Why?
|
| Aged | 4 | 2013 | 163253 | 0.010 |
Why?
|
| Serotonin | 1 | 1984 | 1023 | 0.010 |
Why?
|
| Lymphocytes | 2 | 2002 | 2617 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1996 | 11478 | 0.010 |
Why?
|
| Cell Death | 1 | 2004 | 1708 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4982 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2006 | 3913 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 16687 | 0.010 |
Why?
|
| Child | 3 | 2002 | 77679 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1982 | 647 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2005 | 1613 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1991 | 4151 | 0.010 |
Why?
|
| Blood Pressure | 3 | 1984 | 8551 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1989 | 2147 | 0.010 |
Why?
|
| Phenotype | 3 | 2008 | 16365 | 0.010 |
Why?
|
| Metabolism | 1 | 1979 | 193 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 2014 | 0.010 |
Why?
|
| Pancreas | 1 | 2004 | 1686 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 2002 | 804 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 1525 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1997 | 252 | 0.010 |
Why?
|
| Rabbits | 3 | 1981 | 4892 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 2 | 2005 | 2538 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1998 | 596 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 21752 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 13668 | 0.010 |
Why?
|
| Nervous System | 1 | 1979 | 554 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1997 | 1161 | 0.010 |
Why?
|
| Transgenes | 1 | 1998 | 1009 | 0.010 |
Why?
|
| Directed Molecular Evolution | 1 | 1996 | 160 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2848 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2002 | 1948 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2002 | 1404 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 2749 | 0.010 |
Why?
|
| Life Expectancy | 1 | 1981 | 1184 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 1526 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1997 | 558 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 3085 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5974 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1998 | 2007 | 0.010 |
Why?
|
| Complement Activation | 1 | 1995 | 453 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3800 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1998 | 987 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 35423 | 0.010 |
Why?
|
| Blood Gas Analysis | 2 | 1984 | 382 | 0.010 |
Why?
|
| Prednisone | 1 | 1997 | 1575 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2002 | 2108 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 25043 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 4465 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8343 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1997 | 1402 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 12035 | 0.010 |
Why?
|
| Splenectomy | 1 | 1973 | 395 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 1973 | 291 | 0.010 |
Why?
|
| Platelet Activation | 1 | 1995 | 673 | 0.010 |
Why?
|
| Porins | 1 | 1991 | 81 | 0.010 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 1970 | 26 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 427 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1981 | 6485 | 0.010 |
Why?
|
| Blood Glucose | 2 | 1984 | 6259 | 0.010 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1991 | 214 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1997 | 3144 | 0.010 |
Why?
|
| Meningitis | 1 | 1991 | 216 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1997 | 1836 | 0.010 |
Why?
|
| Colony-Stimulating Factors | 1 | 1990 | 216 | 0.010 |
Why?
|
| Body Weight | 1 | 1981 | 4666 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 3772 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 1991 | 221 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1086 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 918 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15070 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1990 | 349 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2006 | 63119 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1995 | 1127 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1998 | 3748 | 0.010 |
Why?
|
| Nephritis, Hereditary | 1 | 1989 | 88 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 1981 | 2839 | 0.010 |
Why?
|
| Cadaver | 1 | 1992 | 1337 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1970 | 370 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15538 | 0.000 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1989 | 133 | 0.000 |
Why?
|
| Growth Substances | 1 | 1990 | 783 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 570 | 0.000 |
Why?
|
| Morpholines | 2 | 1981 | 573 | 0.000 |
Why?
|
| Open Reading Frames | 1 | 1991 | 810 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 56436 | 0.000 |
Why?
|
| Operon | 1 | 1987 | 363 | 0.000 |
Why?
|
| Hypertension | 2 | 1989 | 8480 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 1375 | 0.000 |
Why?
|
| Prospective Studies | 2 | 2006 | 53280 | 0.000 |
Why?
|
| Hypotension | 1 | 1991 | 880 | 0.000 |
Why?
|
| Prognosis | 2 | 1989 | 29050 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2006 | 23337 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 39045 | 0.000 |
Why?
|
| Interprofessional Relations | 1 | 1969 | 1009 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1991 | 4012 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1984 | 909 | 0.000 |
Why?
|
| Electroshock | 1 | 1981 | 122 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 57768 | 0.000 |
Why?
|
| Ascorbic Acid | 1 | 1984 | 650 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1979 | 7179 | 0.000 |
Why?
|
| Omentum | 1 | 1961 | 170 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1992 | 8321 | 0.000 |
Why?
|
| Base Sequence | 1 | 1991 | 12801 | 0.000 |
Why?
|
| Adenosine | 1 | 1984 | 825 | 0.000 |
Why?
|
| Infant | 1 | 1981 | 35129 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1991 | 13817 | 0.000 |
Why?
|
| Stomach Neoplasms | 1 | 1948 | 1333 | 0.000 |
Why?
|
| Patient Care Team | 1 | 1969 | 2529 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1991 | 18116 | 0.000 |
Why?
|
| Intestinal Obstruction | 1 | 1961 | 424 | 0.000 |
Why?
|
| Dopamine | 1 | 1984 | 1591 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1981 | 1458 | 0.000 |
Why?
|
| Disease | 1 | 1961 | 681 | 0.000 |
Why?
|
| Sex Factors | 1 | 1989 | 10396 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1969 | 7908 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2002 | 77426 | 0.000 |
Why?
|
| Hepatomegaly | 1 | 1973 | 85 | 0.000 |
Why?
|
| Splenic Neoplasms | 1 | 1973 | 100 | 0.000 |
Why?
|
| Splenomegaly | 1 | 1973 | 190 | 0.000 |
Why?
|
| Lymphography | 1 | 1973 | 201 | 0.000 |
Why?
|
| Glucose | 1 | 1984 | 4396 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1991 | 25618 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1973 | 1676 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1979 | 6150 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1973 | 4252 | 0.000 |
Why?
|